Senators Take Aim At Authorized Generics

Three U.S. Senators introduced a bill Thursday that would prohibit brand-name drugmakers from marketing generic versions of their drugs, claiming the practice undermines competition and runs contrary to congressional intent for...

Already a subscriber? Click here to view full article